Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone intravenous PCA versus oral oxycodone titration for moderate to severe cancer pain
ChiCTR2100045210Phase 4Recruiting
- Sponsor
- Jiangxi Provincial People's Hospital
- Start
- Apr 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hydromorphone and oxycodone in cancer pain (2 arms), sponsored by Jiangxi Provincial People's Hospital. Primary endpoints: Success rate of titration on day 1 and Time to successful titration. Started Apr 2021; status: recruiting.
02
Drugs
hydromorphoneoxycodone
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR2100045210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045210.